Corpus Intelligence IC Memo — MUNSON MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — MUNSON MEDICAL CENTER
Investment Committee Memorandum | MI | 401 beds | Grade B | EBITDA uplift $52.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MUNSON MEDICAL CENTER

CCN 230097 | GRAND TRAVERSE, MI | 401 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

MUNSON MEDICAL CENTER is a 401-bed suburban community hospital in GRAND TRAVERSE, MI with $710.9M in net patient revenue and a -7.0% operating margin. The hospital serves a payer mix of 30.3% Medicare, 4.3% Medicaid, and 65.4% commercial.

Thesis: Undervalued. Our ML models identify $52.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.0% to 0.4% (+736bps).

Net Revenue HCRIS$710.9M
Current EBITDA COMPUTED$-49.6M
Operating Margin COMPUTED-7.0%
Occupancy HCRIS65.0%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS32.1%
Distress Probability ML45.2%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
34
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -7.0% places it below the state median. Among 34 size-comparable peers (200-802 beds), the median margin is -7.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (200-802), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MUNSON MEDICAL CENTER (Target)MI401$710.9M-7.0%
HENRY FORD HOSPITALMI670$2.32B-14.8%
BRONSON METHODIST HOSPITALMI439$1.06B-1.4%
TRINITY HEALTH ANN ARBORMI475$1.00B-1.0%
EDWARD W. SPARROW HOSPITALMI425$936.1M-24.5%
ASCENSION ST JOHN HOSPITALMI556$929.1M-9.6%
ASCENSION PROVIDENCE HOSPITALMI527$849.3M-6.5%
WILLIAM BEAUMONT HOSPITAL - TRMI484$747.4M2.3%
W.A. FOOTE MEMORIAL HOSPITALMI331$681.8M-9.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $52.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$14.9M+210bp18mo
Cost to Collect4.5%2.5%$14.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$14.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$8.7M+122bp9mo
Clean Claim Rate88.0%96.0%$455K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$14.9M
Cost to Collect
$14.2M
Denial Rate Reduction
$14.1M
A/R Days Reduction
$8.7M
Clean Claim Rate
$455K
Total EBITDA Uplift$52.3M
Current EBITDA$-49.6M
+ RCM Uplift+$52.3M
Pro Forma EBITDA$2.8M
Current Margin-7.0%
Pro Forma Margin0.4%
WC Released (1x)$27.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-76.3M$196.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-76.3M$191.2M0.00x-100.0%
Bull Case9.0x11.0x$-68.6M$339.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-68.6M$349.7M0.00x-100.0%
Bear Case11.0x10.0x$-83.9M$-40.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-83.9M$-71.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 200-802 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-13.5% / P50=-7.7% / P75=-2.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.